TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,303,075 | -1.1% | 213,515 | +0.4% | 0.11% | +16.5% |
| Q2 2023 | $3,339,318 | +3.4% | 212,560 | +8.5% | 0.09% | +7.1% |
| Q1 2023 | $3,228,517 | +4.3% | 195,905 | -1.2% | 0.08% | -79.8% |
| Q4 2022 | $3,094,429 | +24.5% | 198,361 | +3.5% | 0.42% | +16.9% |
| Q3 2022 | $2,486,000 | +13.3% | 191,635 | +22.6% | 0.36% | +26.8% |
| Q2 2022 | $2,194,000 | +28.6% | 156,288 | +31.2% | 0.28% | +35.9% |
| Q1 2022 | $1,706,000 | -20.6% | 119,119 | -24.4% | 0.21% | -12.9% |
| Q4 2021 | $2,148,000 | +140.5% | 157,552 | +188.9% | 0.24% | +75.2% |
| Q3 2021 | $893,000 | +42.9% | 54,542 | +46.8% | 0.14% | +10.5% |
| Q2 2021 | $625,000 | +28.9% | 37,151 | +39.9% | 0.12% | +15.9% |
| Q1 2021 | $485,000 | +96.4% | 26,555 | +95.4% | 0.11% | +2575.0% |
| Q4 2020 | $247,000 | +19.9% | 13,589 | +17.8% | 0.00% | 0.0% |
| Q3 2020 | $206,000 | -13.1% | 11,533 | -12.7% | 0.00% | -20.0% |
| Q2 2020 | $237,000 | -6.3% | 13,208 | -20.8% | 0.01% | -37.5% |
| Q1 2020 | $253,000 | -35.9% | 16,676 | -16.7% | 0.01% | -33.3% |
| Q4 2019 | $395,000 | +23.1% | 20,023 | +7.4% | 0.01% | -7.7% |
| Q3 2019 | $321,000 | -2.1% | 18,649 | +0.6% | 0.01% | -7.1% |
| Q2 2019 | $328,000 | – | 18,535 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |